Vascular Solutions Reports Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/9/2026
- S&P closes at record high as soft jobs report eases rate-hike concerns
- US suffers unexpected job losses in July, markets dial back rate hike expectations
- Brent climbs $1 on uncertainty over end to Iran war
- Atlassian results seen as 'game changer' for AI kills software worries
- The Trade Desk hit by Wall St downgrades after disappointing Q2 results, outlook
- Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
- S&P closes at record high as soft jobs report eases rate-hike concerns
- US suffers unexpected job losses in July, markets dial back rate hike expectations
- Atlassian results seen as 'game changer' for AI kills software worries
- Microsoft only US hyperscaler with positive free cash flow as AI capex bites
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
Vascular Solutions (VASC) '3-for-3' in 2015; Canaccord Genuity Reiterates Buy
October 21, 2015 11:07 AM EDTCanaccord Genuity reiterated a Buy rating and $41.50 price target on Vascular Solutions (NASDAQ: VASC), following the company's 3Q15 earnings results. VASC reported its 3rd straight quarter beat and raise in 2015, beating consensus' EPS by $0.02.
Analyst Jason Mills commented, "In terms of a beat and raise batting average,... More
Vascular Solutions (VASC) Tops Q3 EPS by 2c; Boosts FY15 Outlook
October 20, 2015 4:07 PM EDTVascular Solutions (NASDAQ: VASC) reported Q3 EPS of $0.27, $0.02 better than the analyst estimate of $0.25. Revenue for the quarter came in at $37 million versus the consensus estimate of $36.41 million.
Vascular Solutions sees FY2015 EPS of $1.03-$1.05, versus the consensus of $1.03. Vascular Solutions sees FY2015... More
